Veli - Pekka Harjola

Learn More
OBJECTIVES The aim of this study was to evaluate the prognostic value of high-sensitivity troponin T (hs-TnT) in addition to clinical risk factors and the CHA2DS2VASc (congestive heart failure, hypertension, 75 years of age and older, diabetes mellitus, previous stroke or transient ischemic attack, vascular disease, 65 to 74 years of age, female) risk score(More)
OBJECTIVES The aim of this study was to determine the risk of major clinical and thromboembolic events after cardioversion for atrial fibrillation in subjects treated with apixaban, an oral factor Xa inhibitor, compared with warfarin. BACKGROUND In patients with atrial fibrillation, thromboembolic events may occur after cardioversion. This risk is lowered(More)
At present, the risk for stroke and the indication for anticoagulant treatment in AF can be estimated by clinical risk factors, eg, the CHADS 2 or the later developed CHA 2 DS 2 VASc score (which assigns 1 point each for a history of congestive heart failure, hypertension, diabetes melli-tus, vascular disease, age ≥65 years, and sex category [female sex],(More)
T ools which estimate the risk of stroke in patients with atrial fibrillation are widely used in clinical practice to help in the choice of antithrombotic strategy. One of the most commonly used is the cardiac failure, hypertension, age, diabetes mellitus, stroke (doubled) [CHADS 2 ] score. 2 Although CHADS 2 and other scores include cardiac failure or(More)
  • 1